{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T14:34:38Z","timestamp":1778250878377,"version":"3.51.4"},"reference-count":25,"publisher":"CAIRN","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,1,23]]},"abstract":"<jats:p>Introduction\u00a0: Les difficult\u00e9s d\u2019observance du traitement antir\u00e9troviral sont un frein \u00e0 l\u2019atteinte de la cible\u00a03 de l\u2019OMS. En Afrique de l\u2019Ouest, il y a un manque de donn\u00e9es probantes sur les mesures de renforcement de l\u2019observance les plus faisables, acceptables et efficaces et sur leur perception par les utilisateurs. L\u2019objectif de cet article est de d\u00e9crire les perceptions des PVVIH (personnes vivant avec le VIH) sur les mesures de renforcement de l\u2019observance au Burkina Faso. M\u00e9thode\u00a0: Dans le cadre du projet THILAO concernant des PVVIH en \u00e9chec de traitement antir\u00e9troviral de 2 e \u00a0ligne \u00e0 Ouagadougou et \u00e0 Bobo-Dioulasso, des mesures de renforcement de l\u2019observance ont \u00e9t\u00e9 propos\u00e9es. Une \u00e9tude socio-anthropologique qualitative, bas\u00e9e sur des entretiens r\u00e9p\u00e9t\u00e9s, a \u00e9t\u00e9 men\u00e9e aupr\u00e8s de 37\u00a0PVVIH pour explorer leurs perceptions. R\u00e9sultats\u00a0: Les 31\u00a0participants pour lesquels les donn\u00e9es \u00e9taient compl\u00e8tes \u00e9taient relativement satisfaits des mesures d\u2019appui \u00e0 l\u2019observance. Trois mesures (pilulier, appels t\u00e9l\u00e9phoniques, sonnerie de rappel) \u00e9taient per\u00e7ues comme simples, efficaces, discr\u00e8tes, adapt\u00e9es aussi bien aux personnes illettr\u00e9es qu\u2019instruites. Trois autres mesures (visites \u00e0 domicile, implication d\u2019un membre de l\u2019entourage, envoi de SMS) n\u2019ont pas \u00e9t\u00e9 tr\u00e8s appr\u00e9ci\u00e9es parce qu\u2019elles exposaient plus au d\u00e9voilement du statut VIH et\/ou \u00e0 la stigmatisation. Deux mesures (groupes de parole, visites fr\u00e9quentes au centre de soins) ont \u00e9t\u00e9 peu utilis\u00e9es car jug\u00e9es fastidieuses. Conclusion\u00a0: Les PVVIH avaient choisi et utilisaient les mesures les mieux adapt\u00e9es \u00e0 leur profil. Les mesures les plus faisables et acceptables identifi\u00e9es telles que le pilulier, l\u2019utilisation du t\u00e9l\u00e9phone pourraient \u00eatre propos\u00e9es aux PVVIH \u00e0 risque d\u2019inobservance dans les programmes ARV (antir\u00e9troviral) ouest-africains.<\/jats:p>","DOI":"10.3917\/spub.196.0855","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T00:25:25Z","timestamp":1589329525000},"page":"855-864","source":"Crossref","is-referenced-by-count":3,"title":["Mesures visant \u00e0 renforcer l\u2019observance pour les antir\u00e9troviraux\u00a0: perceptions et exp\u00e9rience des PVVIH au Burkina Faso"],"prefix":"10.3917","volume":"Vol. 31","author":[{"given":"Lalla","family":"Berth\u00e9-Sanou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u00efmouna","family":"Sanou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdramane","family":"Berth\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rayende","family":"Ou\u00e9draogo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrien B.","family":"Sawadogo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Drabo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raoul","family":"Moh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Tubiana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Slama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Desclaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2273","reference":[{"key":"rb1","unstructured":"1 Conseil National de Lutte contre le sida et les IST. Cadre Strat\u00e9gique de lutte contre le VIH, le Sida et les infections sexuellement transmissibles 2011-2015 (document final). Ouagadougou\u00a0: SP\/CNLS-IST 2010\u00a0juillet."},{"key":"rb2","unstructured":"2 Conseil National de Lutte contre le sida et les IST. Rapport d\u2019activit\u00e9 sur la riposte au sida au Burkina Faso\u00a0: Global Aids Monitoring (GAM) 2018. Ouagadougou\u00a0: CNLS-IST 2018\u00a0juillet."},{"key":"rb3","unstructured":"3 OMS. Strat\u00e9gie mondiale du secteur de la sant\u00e9 contre le VIH 2016-2020\u00a0: vers l\u2019\u00e9limination du VIH. Gen\u00e8ve\u00a0: OMS 2016."},{"key":"rb4","doi-asserted-by":"crossref","unstructured":"4 Iguenane J, Sawadogo I, Marchand C, Beugny A. Concevoir et \u00e9valuer des outils d\u2019\u00e9ducation th\u00e9rapeutique pour les personnes vivant avec le VIH. Sant\u00e9 publique. 2018;30(2):263-71.","DOI":"10.3917\/spub.182.0263"},{"key":"rb5","doi-asserted-by":"crossref","unstructured":"5 Ware NC, Idoko J, Kaaya S, Biraro IA, Wyatt MA, Agbaji O, et al. Explaining adherence success in sub-Saharan Africa: an ethnographic study. PLoS medicine. 2009;6(1):e1000011.","DOI":"10.1371\/journal.pmed.1000011"},{"key":"rb6","unstructured":"6 Scheen A, Giet D. Non-observance th\u00e9rapeutique\u00a0: causes, cons\u00e9quences, solutions. Revue m\u00e9dicale de Li\u00e8ge. 2010;65(5-6):239-45."},{"key":"rb7","doi-asserted-by":"crossref","unstructured":"7 Mbopi-K\u00e9ou F-X, Djomassi LD, Monebenimp F. \u00c9tude des facteurs li\u00e9s \u00e0 l\u2019observance au traitement antir\u00e9troviral chez les patients suivis \u00e0 l\u2019Unit\u00e9 de prise en charge du VIH\/SIDA de l\u2019H\u00f4pital de district de Dschang, Cameroun. Pan African Medical Journal. 2012;12(1).","DOI":"10.11604\/pamj.2012.12.55.1521"},{"key":"rb8","doi-asserted-by":"crossref","unstructured":"8 Guira O, Kabor\u00e9 D, Dao G, Zagr\u00e9 N, Zohoncon T, Pietra V, et al. Pr\u00e9valence de la non-observance \u00e0 la trith\u00e9rapie antir\u00e9trovirale et facteurs cliniques et th\u00e9rapeutiques associ\u00e9s chez les patients \u00e0 Ouagadougou (Burkina Faso). M\u00e9decine et Sant\u00e9 Tropicales. 2016;26(4):396-401.","DOI":"10.1684\/mst.2016.0604"},{"key":"rb9","doi-asserted-by":"crossref","unstructured":"9 Carillon S. Les ruptures de suivi m\u00e9dical des personnes vivant avec le VIH \u00e0 Kayes (Mali). Approche anthropologique. Sciences sociales et sant\u00e9. 2011;29(2):5-39.","DOI":"10.3917\/sss.292.0005"},{"key":"rb10","doi-asserted-by":"crossref","unstructured":"10 P\u00e9tr\u00e9 B, Gagnayre R, De Andrade V, Ziegler O, Guillaume M. From therapeutic patient education principles to educative attitude: the perceptions of health care professionals\u2013a pragmatic approach for defining competencies and resources. Patient preference and adherence. 2017;11:603-617.","DOI":"10.2147\/PPA.S121892"},{"key":"rb11","doi-asserted-by":"crossref","unstructured":"11 Hayes TL, Hunt JM, Adami A, Kaye JA, editors. An electronic pillbox for continuous monitoring of medication adherence. 2006 International Conference of the IEEE Engineering in Medicine and Biology Society; 2006: IEEE.","DOI":"10.1109\/IEMBS.2006.260367"},{"key":"rb12","doi-asserted-by":"crossref","unstructured":"12 Haberer JE, Kahane J, Kigozi I, Emenyonu N, Hunt P, Martin J, et al. Real-time adherence monitoring for HIV antiretroviral therapy. AIDS and Behavior. 2010;14(6):1340-6.","DOI":"10.1007\/s10461-010-9799-4"},{"key":"rb13","doi-asserted-by":"crossref","unstructured":"13 Abdulrahman SA, Rampal L, Ibrahim F, Radhakrishnan AP, Shahar\u00a0HK, Othman N. Mobile phone reminders and peer counseling improve adherence and treatment outcomes of patients on\u00a0ART in Malaysia: A randomized clinical trial. PloS one. 2017;12(5):e0177698.","DOI":"10.1371\/journal.pone.0177698"},{"key":"rb14","doi-asserted-by":"crossref","unstructured":"14 Bangsberg DR, Haberer JE. Lifetime HIV antiretroviral therapy adherence intervention: timing is everything: comment on \u201cmanaged problem solving for antiretroviral therapy adherence\u201d. JAMA internal medicine. 2013;173(4):306-7.","DOI":"10.1001\/jamainternmed.2013.2858"},{"key":"rb15","unstructured":"15 Desclaux A, Lani\u00e8ce I, Ndoye I, Taverne B. L\u2019initiative s\u00e9n\u00e9galaise d\u2019acc\u00e8s aux m\u00e9dicaments antir\u00e9troviraux. Analyses \u00e9conomiques, sociales, comportementales et m\u00e9dicales Paris\u00a0: ANRS. 2002."},{"key":"rb16","unstructured":"16 Kouanda S, Bila B, Berth\u00e9 S, Doulougou B, Meda N, Msellati P, et al. Pratiques de prise en charge des personnes vivant avec le VIH au Burkina Faso Ouagadougou\u00a0: IRSS, Centre Muraz, CMLS\/sant\u00e9 2008."},{"key":"rb17","unstructured":"17 Bergier B. Rep\u00e8res pour une restitution des r\u00e9sultats de la recherche en sciences sociales. Paris\u00a0: l\u2019Harmattan\u00a0; 2000."},{"key":"rb18","doi-asserted-by":"crossref","unstructured":"18 Mucchielli A. Dictionnaire des m\u00e9thodes qualitatives en sciences humaines Armand Colin\u00a0; 2009.","DOI":"10.3917\/arco.mucch.2009.02"},{"key":"rb19","doi-asserted-by":"crossref","unstructured":"19 Kunutsor S, Walley J, Katabira E, Muchuro S, Balidawa H, Namagala\u00a0E, et al. Using mobile phones to improve clinic attendance amongst an antiretroviral treatment cohort in rural Uganda: a cross-sectional and prospective study. AIDS and Behavior. 2010;14(6):1347-52.","DOI":"10.1007\/s10461-010-9780-2"},{"key":"rb20","doi-asserted-by":"crossref","unstructured":"20 Mills EJ, Bakanda C, Birungi J, Chan K, Ford N, Cooper CL, et al. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda. Annals of Internal Medicine. 2011;155(4):209-16.","DOI":"10.7326\/0003-4819-155-4-201108160-00358"},{"key":"rb21","doi-asserted-by":"crossref","unstructured":"21 Lantenois C, Coriat B. La \u00ab\u00a0pr\u00e9qualification\u00a0\u00bb OMS\u00a0: origines, d\u00e9ploiement et impacts sur la disponibilit\u00e9 des antir\u00e9troviraux dans les pays du Sud. Sciences sociales et sant\u00e9. 2014;32(1):71-99.","DOI":"10.1684\/sss.2014.0105"},{"key":"rb22","doi-asserted-by":"crossref","unstructured":"22 Maier C, Mustapic D, Schuster E, Luger A, Eher R. Effect of a pocket-size tablet-dispensing device on glycaemic control in Type\u00a02 diabetic patients. Diabetic medicine. 2006;23(1):40-5.","DOI":"10.1111\/j.1464-5491.2005.01721.x"},{"key":"rb23","doi-asserted-by":"crossref","unstructured":"23 Ky-Zerbo O, Desclaux A, Som\u00e9 J-F, El Asmar K, Msellati P, Obermeyer\u00a0C. La stigmatisation des PVVIH en Afrique\u00a0: analyse de ses formes et manifestations au Burkina Faso. Sant\u00e9 publique. 2014;26(3): 375-84.","DOI":"10.3917\/spub.139.0375"},{"key":"rb24","unstructured":"24 Gru\u00e9nais M-E, Ouattara F. \u00ab\u00a0Des malades comme les autres\u00a0\u00bb ou comment les soignants traitent les malades du sida et la question de la stigmatisation au Burkina Faso. Science et Technique, S\u00e9rie Sciences de la sant\u00e9. 2008;(1):93-100."},{"key":"rb26","unstructured":"26 Desclaux A, Alfieri C. Allaitement, VIH et pr\u00e9vention au Burkina Faso\u00a0: les d\u00e9terminants sociaux ont-ils chang\u00e9\u00a0? Science et Technique, S\u00e9rie Sciences de la sant\u00e9. 2008;(1):117-26."}],"container-title":["Sant\u00e9 Publique"],"original-title":[],"deposited":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T12:22:06Z","timestamp":1701778926000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cairn.info\/revue-sante-publique-2019-6-page-855.htm?ref=doi"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[2020,1,23]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,1,23]]}},"URL":"https:\/\/doi.org\/10.3917\/spub.196.0855","relation":{},"ISSN":["0995-3914"],"issn-type":[{"value":"0995-3914","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1,23]]}}}